Human Papillomavirus (HPV) is a major contributor to cervical cancer and other HPV-related diseases, with certain high-risk genotypes, such as HPV16 and HPV18, being particularly dangerous. Early and accurate detection of these and other high-risk HPV types is critical for effective prevention, diagnosis, and management of HPV-associated conditions.

The Nucleic Acid Detection Kit for 18 High-risk and Low-risk 6&11 Human Papillomavirus (HPV) Genotypes is an advanced diagnostic tool that detects 18 high-risk HPV genotypes—including HPV16, HPV18, HPV26, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV53, HPV56, HPV58, HPV59, HPV66, HPV68, HPV73, and HPV82—as well as 2 low-risk types, HPV6 and HPV11. This kit is designed to analyze clinical samples such as cervical exfoliated cells and reproductive tract secretions, providing comprehensive HPV genotyping to aid in patient risk assessment and management.

The iCassette uses a magnetic bead transfer structure and process technology, as well as a material distributed mixing device structure. It is compatible with the Galaxy: Nano, Lite and Pro. The test can be performed on demand with no minimum batch size requirement, which is advantageous for clinics and hospitals that require rapid results. The fully automated sample magnetic beads extraction to qPCR process provides results in one and a half hours with minimal hands-on time, increasing laboratory efficiency and reducing patient waiting times.

The iCassette 18 High Risk Human Papillomavirus and HPV 6 & 11 Diagnostic Kit is suitable with cervical exfoliated cells, reproductive tract secretions, and saliva. It is stored at 2-8°C and includes internal process control to ensure the accuracy and reliability of each test performed.

By providing detailed insights into the presence of multiple high-risk and low-risk HPV genotypes, this kit enables healthcare providers to take proactive steps in managing HPV-related diseases, ensuring better patient outcomes through early detection and targeted treatment strategies.